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March 14, 2003
Accompanying this letter is an exposure draft of a proposed Statement of Position (SOP), Accounting by
Insurance Enterprises for Deferred Acquisition Costs on Internal Replacements Other Than Those
Specifically Described in FASB Statement No. 97. A summary of the significant provisions of the proposed
SOP is included in the forepart of that document.
The purpose of the exposure draft is to solicit comments from preparers, auditors, and users of financial
statements and other interested parties. The Accounting Standards Executive Committee invites comments
on all matters in the proposed SOP and particularly on the issues listed below. Respondents should refer to
specific paragraph numbers and include reasons for any suggestions or comments.
Internal Replacements
Issue 1: The proposed SOP concludes that an internal replacement is defined as a modification in product
benefits or features that occurs by amendment or rider to an existing contract or by the exchange of an
existing contract for a new contract. Do you agree with this definition of an internal replacement? If not, why
not? Do you agree that the same accounting treatment should apply to a given modification however made,
whether structured as an amendment or rider to an existing contract or as the issuance of a new contract in
replacement of the original contract? Why or why not?
Refer to paragraphs 9 and A3 through A6 of the proposed SOP.
Determining “Not Substantially Different”
Issue 2: The proposed SOP concludes that internal replacements are deemed substantially different from
the replaced contract unless they meet all of the conditions in paragraph 11 of the proposed SOP. Do you
agree that the conditions listed in paragraph 11 of the proposed SOP are the appropriate criteria for
determining whether an internal replacement is not substantially different? Why or why not? Do you
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believe these conditions are articulated clearly enough to lend themselves to consistent interpretation and
application? If not, what guidance would you propose?

Refer to paragraphs 11 through 18 and A12 through A17 of the proposed SOP.
Accounting for Internal Replacements That Are Substantially Different
Issue 3: The proposed SOP concludes that an internal replacement that is deemed to be substantially
different from the replaced contract should be accounted for as an extinguishment of the replaced contract,
which should be treated as lapsed or surrendered. Under the proposed SOP, unamortized deferred
acquisition costs, deferred revenue liabilities, and deferred sales inducement assets from the replaced
contract associated with an internal replacement transaction that is substantially different should not be
deferred in connection with the replacement contract. Do you agree with this conclusion? Why or why not?
Refer to paragraphs 19 and A18 of the proposed SOP.
Accounting for Internal Replacements That Are Not Substantially Different
Issue 4: The proposed SOP concludes that an internal replacement that is determined to be not
substantially different from the replaced contract should be accounted for as a continuation of the replaced
contract. Under the proposed SOP, unamortized deferred acquisition costs, deferred revenue liabilities, and
deferred sales inducement assets attributed to the replaced contract should continue to be deferred in
connection with the replacement contract. Do you agree with this conclusion? Why or why not?
Refer to paragraphs 20 through 24 and A19 through A22 of the proposed SOP.
Unamortized Deferred Acquisition Costs
Issue 5: The proposed SOP concludes that if internal replacements of contracts accounted for under the
guidance of FASB Statements No. 97, Accounting and Reporting by Insurance Enterprises for Certain
Long-Duration Contracts and for Realized Gains and Losses from the Sale of lnvestments, or No. 120,
Accounting and Reporting by Mutual Life Insurance Enterprises and by Insurance Enterprises for Certain
Long-Duration Participating Contracts, are considered not substantially different from the replaced
contracts, the estimated gross profits or margins of the replacement contracts should be treated as
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revisions to the estimated gross profits or margins of the original contracts in the determination of the
amortization of deferred acquisition costs and deferred sales inducement assets and the recognition of
deferred revenues. Do you think this conclusion is practicable? Why or why not, and what alternative
method would you suggest?
Refer to paragraphs 21 and A21 of the proposed SOP.

Costs Related to Internal Replacements
Issue 6: The proposed SOP concludes that acquisition costs incurred in connection with an internal
replacement in which the contracts involved are determined to be not substantially different are deemed to
be costs associated with renewals and should be evaluated for deferral in accordance with the provisions of
FASB Statements No. 60, Accounting and Reporting by Insurance Enterprises, as amended, and No. 97,
Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized
Gains and Losses from the Sale of lnvestments, and No. 97. Do you agree with this conclusion? Why or
why not?
Refer to paragraphs 25 and A23 of the proposed SOP.
Disclosures
Issue 7: The proposed SOP requires that the notes to the financial statements include a description of the
accounting policy applied to internal replacements. Are there any other disclosures related to internal
replacement activity that would be useful to the readers of financial statements? If so, what additional
disclosures would you propose?
Refer to paragraphs 29 and A25 of the proposed SOP.
Effective Date
Issue 8: The proposed SOP would be effective for internal replacements occurring in fiscal years beginning
after December 15, 2003, with early adoption encouraged. Assuming the issuance of a final SOP during the
third quarter of 2003, is the effective date appropriate? Why or why not?
Refer to paragraphs 30 and A26 of the proposed SOP.
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Transition
Issue 9: The proposed SOP would be required to be applied prospectively from the beginning of the year of
adoption and, therefore, unamortized deferred acquisition costs and other balances, such as unearned
revenue on front-end fees and unamortized deferred sales inducements related to internal replacement
transactions occurring prior to the year of adoption of the SOP, would not be permitted to be adjusted to the
amounts that would have been reported had the SOP been in effect when those internal replacements
occurred. Do you agree with these conclusions? Why or why not?
Refer to paragraphs 31, A27, and A28 of the proposed SOP.

Comments on the exposure draft should be sent by e-mail to khekker@aicpa.org, or addressed to Kim
Kushmerick Hekker, Technical Manager, Accounting Standards, File 3162.DAC, American Institute of
Certified Public Accountants, 1211 Avenue of the Americas, New York, NY 10036-8775, in time to be
received by May 14, 2003.

Written comments on the exposure draft will become part of the public record of the AICPA and will be
available for public inspection at the AICPA offices for one year after May 14, 2003.

Sincerely,

Mark V. Sever, CPA
Chair
Accounting Standards
Executive Committee

Deborah H. Whitmore, CPA
Chair
DAC on Internal Replacements
Task Force

Daniel J. Noll, CPA
Director
Accounting Standards
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SUMMARY

This Statement of Position (SOP) provides guidance on accounting by insurance enterprises for deferred
acquisition costs (DAC) on internal replacements other than those specifically described in FASB
Statement No. 97.
The SOP requires, among other things, the following:

•

Internal replacements. An internal replacement is defined as a modification in product benefits or
features that occurs by amendment or rider to an existing contract or by the exchange of an existing
contract for a new contract. In addition, the election of a feature within an existing contract may result in
a modification that would require evaluation under the provisions of this SOP. The legal form of an
internal replacement should not determine the accounting applicable to the transaction. The same
accounting treatment should apply to a given modification however made, whether structured as an
amendment or rider to an existing contract or as the issuance of a new contract in replacement of the
original contract. Certain specified modifications of an existing contract are not considered internal
replacements if they are both contemplated in the original contract and do not change the inherent
nature (see paragraph 8 of this SOP) of the original contract.

•

Determining “not substantially different.” An internal replacement transaction results in a contract that is
substantially different from the replaced contract unless the modification is specifically identified in
paragraph 9 of this SOP as not constituting an internal replacement or if all of the following conditions
exist:
a. The modification does not result in a change in the inherent nature of the contract.
b. An additional deposit, premium, or charge relating to the original benefit, in excess of amounts
contemplated in the original contract, is not required to effect the transaction.
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c.

There is no net decrease in the balance available to the contract holder, when applicable.

d. The modification does not result in a change to either the amortization method or revenue
classification of the contract.
e. Additional benefits, whether elected as a result of provisions of the original contract or
provisions added subsequently, do not become the primary benefits under the contract.

•

Accounting for Internal Replacements That Are Substantially Different. An internal replacement that is
deemed to be substantially different from the replaced contract should be accounted for as an
extinguishment of the replaced contract, which should be treated as lapsed or surrendered.
Unamortized deferred acquisition costs, deferred revenue liabilities, and deferred sales inducement
assets from the replaced contract associated with an internal replacement transaction that is
substantially different should not be deferred in connection with the replacement contract.

•

Accounting for internal replacements that are not substantially different. An internal replacement that is
determined to be not substantially different from the replaced contract should be accounted for as a
continuation of the replaced contract. Unamortized deferred acquisition costs, deferred revenue
liabilities, and deferred sales inducement assets associated with the replaced contract should continue
to be deferred in connection with the replacement contract. Other balances that are determined based
on activity over the life of the contract, such as a minimum guaranteed death benefit (MGDB), which
under the provisions of the proposed SOP Accounting and Reporting by Insurance Enterprises for
Certain Nontraditional Long-Duration Contracts and for Separate Accounts are determined based on
estimated gross profits and benefit costs, should consider the entire life of the contract, including
activity during the term of the original (replaced) contract.

•

Sales inducements. New sales inducements that otherwise meet the criteria in the proposed SOP
Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts
and for Separate Accounts offered in conjunction with an internal replacement that is not substantially
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different from the replaced contract, should be accounted for as if they were explicitly identified in the
original contract at inception.

•

Costs and assessments related to internal replacements. Acquisition costs related to and front-end fees
incurred in connection with internal replacement activity should be evaluated for deferral in accordance
with the provisions of Financial Accounting Standards Board (FASB) Statements of Financial
Accounting Standards No. 60, Accounting and Reporting by Insurance Enterprises, as amended, and
No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and
for Realized Gains and Losses from the Sale of lnvestments. Acquisition costs incurred in connection
with an internal replacement in which contracts are determined to be not substantially different are
deemed to be costs associated with renewals.

•

Recoverability. Unamortized deferred acquisition costs and the present value of future profits1 continue
to be subject to loss recognition testing in accordance with the provisions of FASB Statement No. 60.

•

Disclosures. The notes to the financial statements should clearly describe the accounting policy applied
to internal replacements.

This SOP is effective for internal replacements occurring in fiscal years beginning after December 15, 2003,
with earlier adoption encouraged. Restatement of previously issued annual financial statements is not
permitted. Initial application of this SOP should be as of the beginning of an entity’s fiscal year (that is, if the
SOP is adopted prior to the effective date and during an interim period, all prior interim periods of the year
of adoption should be restated).

This SOP should be applied prospectively from the beginning of the year of adoption and, therefore,
unamortized deferred acquisition costs and other balances, such as unearned revenue on front-end fees
1

As discussed in Emerging Issues Task Force (EITF) Issue No. 92-9, Accounting for the Present Value of Future Profits Resulting
from the Acquisition of a Life Insurance Company.
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and unamortized deferred sales inducements, related to internal replacement transactions occurring prior to
the year of adoption of this SOP should not be adjusted to the amounts that would have been reported had
this SOP been in effect prior to the year of adoption.
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FOREWORD

The accounting guidance contained in this document has been cleared by the Financial Accounting
Standards Board (FASB). The procedure for clearing accounting guidance in documents issued by the
Accounting Standards Executive Committee (AcSEC) involves the FASB reviewing and discussing in public
board meetings (1) a prospectus for a project to develop a document, (2) a proposed exposure draft that
has been approved by at least 10 of AcSEC’s 15 members, and (3) a proposed final document that has
been approved by at least 10 of AcSEC’s 15 members. The document is cleared if at least four of the seven
FASB members do not object to AcSEC undertaking the project,1 issuing the proposed exposure draft or,
after considering the input received by AcSEC as a result of the issuance of the exposure draft, issuing the
final document.
The criteria applied by the FASB in its review of proposed projects and proposed documents include the
following.
1.

The proposal does not conflict with current or proposed accounting requirements, unless it is a
limited circumstance, usually in specialized industry accounting, and the proposal adequately
justifies the departure.

2.

The proposal will result in an improvement in practice.

3.

The AICPA demonstrates the need for the proposal.

4.

The benefits of the proposal are expected to exceed the costs of applying it.

In many situations, prior to clearance, the FASB will propose suggestions, many of which are included in
the documents.

1

At the time AcSEC undertook the project, at least five of the seven FASB members were required to not object to AcSEC undertaking
this project.
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ACCOUNTING BY INSURANCE ENTERPRISES
FOR DEFERRED ACQUISITION COSTS ON INTERNAL REPLACEMENTS
OTHER THAN THOSE SPECIFICALLY DESCRIBED IN FASB STATEMENT NO. 97
INTRODUCTION AND BACKGROUND
1. Insurance enterprises may offer existing contract holders new products or modifications to existing
contracts1 for various reasons, such as increasing administrative efficiency and improving the competitive
position of the contract to enhance contract holder satisfaction and retention. For example, at the time
universal life-type contracts became popular, they were often purchased as replacements for traditional life
insurance contracts issued by the same enterprise. In those cases, the contract holder often used the cash
surrender value of the previous contract to make an initial premium deposit for the new, universal life-type
contract.

2. Financial Accounting Standards Board (FASB) Statement of Financial Accounting Standards No. 97,
Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized
Gains and Losses from the Sale of lnvestments, refers to the replacement by an insurance enterprise of
one of its traditional life insurance contracts by a universal life-type contract as an internal replacement.
FASB Statement No. 97 specifies that unamortized deferred acquisition costs related to traditional life
insurance contracts replaced with universal life-type contracts issued by the same insurance enterprise
shall not be deferred in connection with the replacement contract.

3. Diversity in practice exists in accounting for internal replacements other than those specified in FASB
Statement No. 97, which discusses internal replacements of traditional life insurance contracts with
universal life-type contracts only and does not address the accounting for other internal replacements (such
as traditional life with traditional life, universal life with universal life, annuity with annuity). AICPA Practice
Bulletin 8, Application of FASB Statement No. 97 to Insurance Enterprises, issued in November 1990,
clarifies that the accounting specified by FASB Statement No. 97 for internal replacement transactions
applies only to the replacement of traditional insurance contracts with universal life-type contracts. Practice

1

Terms defined in the Glossary are set in boldface type the first time they appear in text.
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Bulletin 8 paragraphs 18 and 19 state:

.18 Question 7: Does the accounting specified by FASB Statement No. 97, paragraph 26,
for internal replacement transactions apply only to the replacement of traditional insurance
contracts by universal life-type contracts?
.19 Answer 7: Yes, FASB Statement No. 97 addresses only replacements of traditional
insurance contracts by universal life-type contracts. The accounting for other internal
replacements should be based on the circumstances of the transaction. Paragraphs 70 to
72 of FASB Statement No. 97 discuss the Board’s rationale for requiring recognition of loss
on the termination of the replaced contract.

4. The basis for conclusions of FASB Statement No. 97 discusses alternative views of accounting for
internal replacements. Paragraph 71 of the Statement discusses two alternative views rejected by the
Board:
a. Continued deferral of costs related to replacement contracts is appropriate based on the
continuation of the customer relationship:
The replacement of a traditional life insurance contract with a universal life-type contract typically
results in the need to account for an amount equal to the sum of (a) the unamortized acquisition costs
associated with the replaced contract and (b) the difference between the cash surrender value and
the previously recorded liability for policy benefits related to the replaced contract. The AICPA Issues
Paper suggested that this net amount should be deferred and amortized as part of the capitalized
acquisition costs of the new book of universal life-type contracts. The Issues Paper took the position
that the universal life-type replacement contract represented a continuing relationship between the
insurer and the policyholder, and maintained that the new contract represented only a change in the
form of the insurance protection.

b. Continued deferral of costs related to replaced contracts more closely equates the cost of
replacement contracts and contracts issued to new customers:
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Some respondents also suggested that the incremental costs of replacement transactions are
usually less than the costs of sales to new policyholders. In their view, the continued deferral of net
amounts related to replaced contracts more nearly equates the costs of contracts issued to
different classes of policyholders.

5. As stated in paragraph 72 of FASB Statement No. 97:
The Board rejected those proposals. The Board recognizes that an insurance enterprise
that conducts an internal replacement program may be motivated by a desire to retain its
customer base and that the alternative to replacement may be loss of that base. That
objective is not, however, different from the objectives of similar transactions undertaken by
insurance enterprises and other enterprises for which continued deferral of costs is not
permitted, including the refunding of debt.

APPLICABILITY AND SCOPE
6. This Statement of Position (SOP) applies to all entities to which FASB Statement No. 60, Accounting
and Reporting by Insurance Enterprises, as amended, applies, hereinafter referred to as insurance
enterprises.2

CONCLUSIONS
7. If an internal replacement (as defined in paragraph 9 of this SOP) occurs and the rights and obligations
of the parties to the contract are not substantially different from what those rights and obligations were
under the original or replaced contract, the replacement contract is accounted for as a continuation of the
original or replaced contract.

Therefore, unamortized deferred acquisition costs, deferred revenue

liabilities, and deferred sales inducement assets attributed to the replaced contract should continue to be
deferred in connection with the replacement contract.

2

Financial Accounting Standards Board Statement of Financial Accounting Standards No. 60, Accounting and Reporting by Insurance
Enterprises, as amended, applies to life insurance enterprises, property and liability insurance enterprises, title insurance
enterprises, mortgage guaranty insurance enterprises, assessment enterprises, and fraternal benefit societies.
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Inherent Nature
8. This SOP uses the concept of inherent nature in determining whether modifications to contracts result
in contracts that are not substantially different. For purposes of this SOP, the mortality risk, morbidity risk,
and contractual rights and provisions for the determination of the contract holder’s investment return are the
most significant factors in determining the inherent nature of the contract. Items to consider in determining
the inherent nature of a contract include:
a. The kind and degree of mortality risk, if any (see paragraphs 12 and 13 of this SOP for
examples).
b. The kind and degree of morbidity risk, if any (see paragraphs 12 and 13 of this SOP for
examples).
c.

The nature of the investment return rights and provisions, if any, for example, whether under
the provisions of the contract the investment returns are set periodically at the discretion of the
insurance enterprise, determined by formula, or determined based on a pass-through of actual
investment performance, as well as whether the contract provides multiple investment
allocation alternatives to the contract holder. The nature of a contract’s investment return rights
and provisions refers to the contractual provisions relative to the determination of the
investment return and does not reference the specific nature or the risk profile of the
investment or the level of investment return.

Internal Replacements
9. An internal replacement is defined as a modification in product benefits or features that occurs by
amendment or rider to an existing contract or by the exchange of an existing contract for a new contract. In
addition, the election of a feature within an existing contract may result in a modification that would require
evaluation under the provisions of this SOP. The legal form of an internal replacement should not determine
the accounting applicable to the transaction. The same accounting treatment should apply to a given
modification no matter how it is made; for example, whether it takes the form of an amendment or rider to
an existing contract, or the issuance of a new contract in replacement of the original contract.
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10. A modification of an existing contract is not considered an internal replacement if it is both
contemplated in the original contract and does not change the inherent nature of the original contract. The
following are modifications made in accordance with the original contract provisions that are not considered
internal replacements:
a. Changes in cost of insurance charges, crediting rates, or similar provisions within ranges
outlined in the contract without any other change in benefits.
b. Changes in the allocation of the contract holder’s account balance among investment
alternatives provided for in the contract, even if reallocated 100 percent to a specific investment
alternative.
c.

Additional investment allocation alternatives added to a contract with multiple investment
alternatives.

d. Provisions that allow the contract holder to elect inflation adjustments to policy coverage
amounts.
e. Paid-up additions added to life insurance contracts.
All other modifications not specifically listed above are considered internal replacements and should be
evaluated under the criteria in paragraph 11 of this SOP.

Determining “Not Substantially Different”
11. An internal replacement is deemed not substantially different from the replaced contract only if all of
the following conditions exist:
a. The modification does not result in a change in the inherent nature of the contract.
b. An additional deposit, premium, or charge relating to the original benefit, in excess of amounts
contemplated in the original contract, is not required to effect the transaction.
c.

There is no net decrease in the balance available to the contract holder, when applicable.

d. The modification does not result in a change to either the amortization method or revenue
classification of the contract.
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e. Additional benefits, whether elected as a result of provisions of the original contract or
provisions added subsequently, do not become the primary benefits under the replacement
contract.
An internal replacement meeting the conditions above results in a contract that is not substantially different
from the replaced contract, and should be accounted for in accordance with paragraphs 20 to 24 of this
SOP.

Inherent Nature
12. The following are examples of modifications that do not change the inherent nature of the replaced
contract and the supporting rationale:
a. The addition of new investment allocation alternatives to a contract that previously had
multiple investment allocation alternatives but did not contemplate the addition of new
investment allocation alternatives in the original contract provisions. The contractual rights and
provisions related to the determination of contract holder’s investment return remain the pass
through of actual investment performance resulting from the investment alternatives selected
by the contract holder.
b. Modification of a general account deferred annuity with a declared interest rate that is set at
the discretion of the insurance enterprise to a market value adjusted (MVA) annuity (a contract
paying a specified interest rate if held to a stated date but an adjusted value if terminated
prematurely) with a declared interest rate that is set at the discretion of the insurance
enterprise. Only the nature of the termination provisions is changed, as the MVA annuity pays
an adjusted value only if the contract is terminated prematurely. Also, a difference in the level
of declared interest rates does not change the contractual rights and provisions related to the
determination of the contract holder’s investment return.
c.

Modification of a disability income contract to a disability income contract with a long-term care
rider. Provided that the primary benefit remains disability income, the inherent nature of the
contract has not changed.
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d. The addition of or enhancement to a guaranteed minimum income benefit (GMIB) or other
annuitization guarantee on a deferred annuity. This type of modification does not change the
fundamental nature of the investment return right during the accumulation phase of the
contract, which remains the pass through of actual investment performance resulting from the
investment alternatives selected by the contract holder. The GMIB is an additional feature that
does not negate the nature of the original investment return provisions; it is the purchase of an
additional benefit. The contractual rights and provisions related to the determination of the
contract holder’s investment return and the kind and degree of mortality risk have not
changed; only the annuitization guarantee has changed.
e. The addition of a guaranteed minimum accumulation benefit (GMAB) on a variable annuity.
The contractual rights and provisions related to the determination of the contract holder’s
investment return prior to the impact of the GMAB, which is a separate derivative benefit, have
not changed, as the actual investment performance that results from the investment options
selected by the contract holder is still passed through to the contract holder. The GMAB is an
additional feature that does not negate the nature of the original investment return provisions;
it is the purchase of an additional benefit. The addition of a GMAB benefit protects a contract
holder from certain downturns in the market not dissimilar to a situation where a put is
purchased to protect the downside risk of a stock investment. A limitation on the upside
return, however, by definition results in a contract that would not be considered a variable
contract under the guidance of the proposed SOP Accounting and Reporting by Insurance
Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts,
and results in a substantially different contract. The GMAB would be classified and accounted
for as a derivative under FASB Statement No. 133, Accounting for Derivative Instruments and
Hedging Activities, as amended, and FASB Derivative Implementation Issue B8, Identification
of the Host Contract in a Nontraditional Variable Annuity Contract.
These modifications satisfy the condition in paragraph 11(a) of this SOP, but would need to be evaluated
under the conditions in paragraph 11(b), (c), (d), and (e).
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13. The following are examples of modifications that change the inherent nature of the replaced contract
and the supporting rationale:
a. Replacement of a term life insurance contract with a whole life insurance contract. This
modification results in contracts with different inherent natures; although both contracts contain
similar mortality risk, the whole life insurance contract also contains a significant investment
component that does not exist in the term life contract.
b. Replacement of a variable annuity contract that provides a nominal minimum guaranteed death
benefit (MGDB) with a variable annuity that provides a significant MGDB. This modification
results in a contract with a different inherent nature because the annuity contract that provides
a significant MGDB contains a significant mortality component, whereas the other contract
does not, thereby resulting in a change in the degree of mortality risk.
c.

Replacement of a disability income contract with a long-term care contract. This modification
involves a change in the kind of morbidity risk.

d. Replacement of a universal life-type contract with a life-contingent payout annuity contract. This
modification involves a change in the kind of mortality risk.
e. Changes between discretionary and formulaic investment crediting methodologies within the
initial and replacement contracts. This modification involves a change in the contractual rights
and provisions related to the determination of the contract holder’s investment return. While
the return credited could in fact be the same amount under both crediting methodologies, the
rights of the contract holder are substantially different. In one case, the contract holder has a
contractual right to a return determined in accordance with the formula specified in the contract.
In the other case, the contract holder’s right is limited to a return determined in accordance with
the minimum guaranteed crediting rate, although the issuer may credit a higher rate solely at its
discretion.
f.

Replacement of a general account declared interest rate deferred annuity in which the interest
rate is set at the discretion of the insurance enterprise with a deferred annuity in which the
crediting rate is determined contractually by reference to a pool of assets, an index, or other
specified formula. This modification involves a change from a discretionary to a formulaic
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interest crediting methodology, thereby changing the contractual rights and provisions related
to the determination of the contract holder’s investment return as described in paragraph 13(e)
of this SOP.
g. Replacement of a variable annuity contract with a general account fixed contract, or vice versa.
This modification results in contracts with different inherent natures because the contractual
rights and provisions related to the determination of the contract holder’s investment return
have changed.

A general account fixed contract provides for a return determined at the

discretion of the issuer, subject to contractual minimum guaranteed rates.

In contrast, a

variable annuity contract provides for the pass through of actual investment performance
resulting from the investment alternatives selected by the contract holder.

Additional Deposit, Premium, or Charge
14. The requirement of an additional deposit, premium, or charge related to the benefits provided by the
replaced contract that is in excess of amounts contemplated in the original contract, whether explicit or
implicit, results in a substantially different contract. For example, an increase in premiums in excess of the
amount that is commensurate with an increase in the contractual benefits is an implicit additional premium
on the original benefit.

Net Decrease in Balance Available to the Contract Holder
15. A net decrease in the balance available to the contract holder prior to surrender charges as a result of
the internal replacement transaction results in a substantially different contract. For example, if the account
balance of a FASB Statement No. 97 universal life contract prior to surrender charges is $100 and a $5
surrender charge is imposed, the resulting $95 credited to the replacement contract (prior to the
consideration of any new surrender charges) results in a substantially different contract. However, if an
immediate bonus of $5 or more were credited to the replacement contract as well, there would be no net
decrease to the balance available to the contract holder and the internal replacement results in a contract
that was not substantially different provided the other conditions of paragraph 11 are satisfied.
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Change in Amortization Method or Revenue Classification
16. A modification that changes either the amortization method or revenue classification of the replaced
contract results in a substantially different contract. For example, a modification that results in either a
change from amortization of deferred acquisition costs (DAC) in proportion to premium revenue to
amortization based on the emergence of estimated gross profits or a change in revenue classification from
reporting premium as revenue to reporting deposits and cost of insurance results in substantially different
contracts.
Primary Benefits
17. Additional benefits, whether elected pursuant to provisions of the original contract or provisions added
subsequently, would not result in a substantially different contract, provided that the additional benefits do
not become the primary benefits under the contract and provided the other conditions of paragraph 11 are
satisfied.
Substance of the Contract
18. In determining whether an internal replacement is substantially different, the substance of the contract,
not just its legal classification, must also be evaluated. For example, a mutual insurance enterprise may
issue an annuity contract that is “participating” only in legal form; the contract indicates that the insurance
enterprise does not expect to pay a dividend on the contract and, therefore, the contract holder does not
anticipate receiving a policyholder dividend. A subsequent internal replacement of such a nonsubstantive
“participating” annuity with a nonparticipating annuity would not result in a substantially different contract if
the other conditions of paragraph 11 of this SOP are satisfied.

Accounting for Internal Replacements That Are Substantially Different
19. An internal replacement that is deemed to be substantially different from the replaced contract should
be accounted for as an extinguishment of the replaced contract, which should be treated as lapsed or
surrendered. Unamortized deferred acquisition costs, deferred revenue liabilities, and deferred sales
inducement assets from the replaced contract associated with an internal replacement transaction that is
substantially different should not be deferred in connection with the replacement contract.
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Accounting for Internal Replacements That Are Not Substantially Different
20. An internal replacement that is determined to be not substantially different from the replaced contract
should be accounted for as a continuation of the replaced contract. Unamortized deferred acquisition costs,
deferred revenue liabilities, and deferred sales inducement assets associated with the replaced contract
should continue to be deferred in connection with the replacement contract.

21. For contracts accounted for under FASB Statements No. 97 and No. 120, Accounting and Reporting by
Mutual Life Insurance Enterprises and by Insurance Enterprises for Certain Long-Duration Participating
Contracts, the estimated gross profits or margins of the replacement contracts are treated as revisions to
the estimated gross profits or margins of the replaced contracts in the determination of the amortization of
deferred acquisition costs and deferred sales inducement assets and the recognition of deferred revenues.
For contracts to which the FASB Statement No. 91, Accounting for Nonrefundable Fees and Costs
Associated with Originating or Acquiring Loans and Initial Direct Costs of Leases, (interest method)
amortization methodology is applied, the replacement contract represents revisions to the cash flows of the
replaced contract, and unamortized deferred acquisition costs and deferred sales inducement assets are
adjusted accordingly. Other balances that are determined based on activity over the life of the contract,
such as a MGDB, which under the provisions of the proposed SOP Accounting and Reporting by Insurance
Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts are determined
based on estimated gross profits and benefit costs, should be calculated considering the entire life of the
contract, including activity during the term of the original (replaced) contract.

22. For contracts accounted for under FASB Statement No. 60, the replacement contract should be viewed
as a “prospective revision” of the old contract with unamortized deferred acquisition costs adjusted
accordingly on a prospective basis. Under a prospective revision methodology, the DAC and benefit liability
balances at the time of replacement are unchanged. Future increases and decreases to the DAC and benefit
reserve balances would reflect the revised revenue expected from the replacement contract at the time of
replacement. That preserves the “lock-in” principle and is consistent with the treatment of other premium
changes on indeterminate premium life insurance and guaranteed renewable health insurance contracts
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accounted for under the provisions of FASB Statement No. 60. This prospective revision methodology must
be applied consistently for liabilities for policy benefits and unamortized deferred acquisition costs.

23. New sales inducements offered in conjunction with an internal replacement that is not substantially
different from the replaced contract should be accounted for as if explicitly identified in the original contract
at inception. A sales inducement asset can be recognized provided that it otherwise meets the criteria in
the proposed SOP Accounting and Reporting by Insurance Enterprises for Certain Nontraditional LongDuration Contracts and for Separate Accounts.

24. In certain situations, an insurance enterprise may assess a surrender charge on the replaced contract
that is offset by an immediate sales inducement on the replacement contract that is equal to or greater than
the surrender charge. In this situation, the insurance enterprise should offset any surrender charges
assessed against the contract holder’s account balance under the replaced contract against any stated
immediate sales inducement to determine the amount of the deferred sales inducement asset to be
recognized.

Costs Related to Internal Replacements
25. Acquisition costs related to internal replacement activity should be evaluated for deferral in accordance
with the provisions of FASB Statements No. 60 and No. 97, as appropriate. Costs eligible for deferral in
acquiring an insurance contract are defined and described in paragraph 28 of FASB Statement No. 60,
which states:
Acquisition costs are those costs that vary with and are primarily related to the acquisition of new
and renewal insurance contracts. Commissions and other costs … that are primarily related to
insurance contracts issued or renewed during the period in which the costs are incurred shall be
considered acquisition costs.

26. Acquisition costs incurred in connection with an internal replacement where the contracts involved are
determined to be not substantially different, are deemed to be costs associated with renewals.
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Assessments Related to Internal Replacements
27. Front-end fees assessed in connection with an internal replacement should be evaluated for deferral in
accordance with existing accounting literature. For contracts accounted for under FASB Statements No. 91,
97, and No. 120, both new and existing front-end fees on internal replacements that are not substantially
different would be adjusted to reflect the revisions to the estimated gross profits and margins.

Recoverability
28. Unamortized deferred acquisition costs and present value of future profits continue to be subject to
premium deficiency testing in accordance with the provisions of FASB Statement No. 60.

Disclosures
29. The notes to the financial statements should describe the accounting policy applied to internal
replacements.

EFFECTIVE DATE AND TRANSITION
30. The provisions of this SOP are effective for internal replacements occurring in fiscal years beginning
after December 15, 2003 with earlier adoption encouraged. Restatement of previously issued annual
financial statements is not permitted. Initial application of this SOP should be as of the beginning of an
entity’s fiscal year (that is, if the SOP is adopted prior to the effective date, all prior interim periods of the
year of adoption should be restated).

31. The provisions of this SOP should be applied prospectively from the beginning of the year of adoption.
Unamortized deferred acquisition costs and other balances, such as unearned revenue on front-end fees
and unamortized deferred sales inducements, related to internal replacement transactions occurring prior to
the year of adoption of this SOP should not be adjusted to the amounts that would have been reported had
this SOP been in effect when the internal replacements occurred. When the financial statements of the year
of adoption are presented separately or included in comparative financial statements, the notes to the
financial statements should disclose (a) the fact that this SOP has been adopted and the effective date of
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adoption, and (b) the nature of any differences in accounting principles or financial statement presentation
applicable to the financial statements presented that resulted from adoption of the SOP. Disclosure of pro
forma amounts is not required.

32. For purposes of applying paragraph 10 of this SOP, features present in the contract at the date of
adoption of this SOP are to be considered to have been present in the original contract.

The provisions of this Statement need not be applied to immaterial items.
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APPENDIX A
BASIS FOR CONCLUSIONS
Discussion Paper
A1.

In 1999, the American Institute of Certified Public Accountants Insurance Companies Committee

issued a discussion paper, Accounting by Life Insurance Enterprises for Deferred Acquisition Costs on
Internal Replacements Other Than Those Covered by FASB Statement No. 97, for informal public
comment. Eleven comment letters were received with differing responses to the accounting alternatives
presented.

A2.

The discussion paper included three alternative accounting views to be considered:
a. The accounting guidance provided in Financial Accounting Standards Board (FASB) Statement
of Financial Accounting Standards No. 97, Accounting and Reporting by Insurance Enterprises
for Certain Long-Duration Contracts and for Realized Gains and Losses from the Sale of
lnvestments, for internal replacements of traditional life products with universal life-type
products should be extended by analogy to all types of internal replacement transactions.
b. Internal replacement transactions represent a continuation of a contractual relationship and,
therefore, the deferred acquisition costs (DAC) relating to the original contract and any new
deferred acquisition costs should be capitalized and amortized over the life of the new contract
assuming appropriate recoverability tests are met.
c.

Internal replacements of one insurance or investment contract with another insurance or
investment contract with substantially different terms should be accounted for similar to an
extinguishment of debt.

Internal Replacements
A3.

The Accounting Standards Executive Committee (AcSEC) concluded that, for purposes of this

Statement of Position (SOP), an internal replacement is defined as a modification in product benefits or
features that occurs by amendment or rider to an existing contract or by the exchange of an existing
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contract for a new contract. The election of a feature within an existing contract may result in a modification
that would require evaluation under the provisions of this SOP, as described in paragraph 10 of this SOP.
The legal form of an internal replacement should not determine the accounting applicable to the
transaction, as accounting should be based on the substance of the transaction.

A4.

AcSEC concluded that certain changes, made in accordance with existing contract provisions,

would not result in an internal replacement if the changes were specifically contemplated in the original
contract and the nature of these changes is such that the changes would not result in a contract that would
be considered substantially different if evaluated under the terms of paragraph 11 of this SOP. These
contractual elections are to be clearly and explicitly stated in the original contract, with terms that are fixed
and determinable and specific enough so the contract holder is able to evaluate whether to elect the feature
in current and future market conditions. Contractual provisions that allow the contract holder to elect to add
future coverage at then-current rates, subject to a stated minimum and maximum, generally are not specific
enough to satisfy this requirement.

A5.

Many long-duration contracts, particularly those accounted for under FASB Statement No. 97,

contain features that are flexible and discretionary and, in general, practice does not view the utilization of
these elections by the contract holder as an extinguishment of the original contract. AcSEC was concerned
that, given the flexibility of many of these contract designs, benefit and feature elections could be designed
such that the execution of these elections could change the inherent nature of the original contract.
Therefore, AcSEC concluded that if changes made in accordance with existing contract provisions changed
the inherent nature of the replaced contract or the replaced contract’s accounting classification, the change
affected the overall substance of the replaced contract and should be accounted for as an extinguishment
of the replaced contract even if the change was a result of an election within existing contract provisions.

A6.

Many long-duration contracts contain insurance and administrative charges and crediting rates that

can be changed at the discretion of the insurance enterprise. Such changes are made in accordance with
the terms of the contract and do not constitute an extinguishment and replacement of the contract. For
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long-duration contracts that provide for a pass-through of investment performance based on investment
alternatives selected by the contract holder, providing additional investment allocation alternatives does not
change the inherent nature of the original contract because the contract holder is still receiving a passthrough of the investment results of the investment allocations selected.

Substantially Different Concept
A7.

In general, life insurance and annuity products are financial instruments. The insurance enterprise

has a contractual obligation to deliver cash and the customer has a contractual right to receive cash.
Paragraph 15 of FASB Statement No. 97 requires that investment contracts issued by an insurance
enterprise be accounted for in a manner consistent with the accounting for interest-bearing instruments.
Paragraph 72 of FASB Statement No. 97 refers to Accounting Principles Board (APB) Opinion No. 26, Early
Extinguishment of Debt, as amended by FASB Statement No. 76, Extinguishment of Debt, and as
subsequently amended by FASB Statements No. 125, Accounting for Transfers and Servicing of Financial
Assets and Extinguishments of Liabilities, and 140, Accounting for Transfers and Servicing of Financial
Assets and Extinguishments of Liabilities—a replacement of FASB Statement No. 125, as the governing
literature, which requires the write-off of unamortized costs associated with extinguished debt when the
extinguished debt is relieved by a new liability to the same party. Emerging Issues Task Force (EITF) Issue
No. 96-19, Debtor’s Accounting for a Modification or Exchange of Debt Instruments, interpreted the
guidance in FASB Statement No. 125 to conclude that certain debt exchanges do not represent substantive
modifications to existing debt, resulting in deferral of both unamortized amounts related to the old debt and
new fees related to the new debt, and amortization of those amounts over the life of the new debt. FASB
Statement No. 125 was superseded by FASB Statement No. 140, but the guidance in FASB Statement No.
125 that was interpreted by EITF Issue No. 96-19 was carried forward to FASB Statement No. 140 without
reconsideration.

A8.

AcSEC believes instruments issued by financial institutions should be accounted for consistently,

as noted in FASB Statement No. 97, paragraph 39: “While many investment contracts are issued primarily
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by insurance enterprises, the Board believes that similar financial instruments should be accorded similar
treatment regardless of the nature of the issuing enterprise.”

A9.

In EITF Issue No. 96-19, the EITF reached a consensus that an exchange of debt instruments with

substantially different terms should be accounted for and reported in the same manner as an
extinguishment. The EITF observed that a debtor could achieve the same economic effect by making a
substantial modification of the terms of an existing debt instrument. Accordingly, the EITF reached a
consensus that a substantive modification of terms should be accounted for and reported in the same
manner as an extinguishment. Substantive modifications of debt terms materially affect the present value of
future cash flows on the debt, necessitating the abandonment of the existing amortization with “fresh start”
measurements.

A10.

In reaching the conclusion above, however, the EITF explicitly acknowledged that an exchange or

modification in terms that is not substantially different does not result in an extinguishment. The EITF went
on to provide guidance that debt instruments are substantially different if the present value of the cash flows
under the terms of the new debt instrument is at least 10 percent different from the present value of the
remaining cash flows under the terms of the original instrument. Detailed guidance is provided on
calculating the present value of cash flows for purposes of applying the 10 percent test. Although insurance
contracts may contain features not common to debt instruments, both are long-term obligations; thus,
AcSEC concluded that analogy to EITF Issue No. 96-19 is appropriate but was not able to fully apply the
framework of EITF Issue No. 96-19 due to the existence of guidance in FASB Statements No. 60 and No.
97 for determining whether acquisition costs can be deferred and due to the complex nature of many
insurance and investment contracts.

A11.

AcSEC considered a 10 percent test similar to that adopted by the EITF. AcSEC ultimately

concluded that such analyses would not be reliable in reaching a conclusion concerning contract similarity
as the conclusion could be manipulated due to the potential subjectivity of assumptions and complex nature
of many insurance and investment contracts. Rather, AcSEC has adopted a qualitative analysis to be used
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in determining whether replacement or modification of insurance or investment contracts results in the
contracts being considered substantially different. AcSEC believes that use of a qualitative analysis will
result in an improvement in practice by providing a framework to evaluate internal replacements. AcSEC
believes that framework will narrow the circumstances that will result in costs associated with the replaced
contract continuing to be deferred with the replacement contract, and will provide sufficient flexibility for
continued deferral when appropriate.

Conditions for Determining “Not Substantially Different”
A12.

AcSEC concluded that certain contract additions or modifications are always indicative of

substantially different contracts. In situations where the inherent natures of the replaced and replacement
contracts are different, AcSEC concluded that it would be appropriate to consider the contracts to be
substantially different for financial reporting purposes. Therefore, AcSEC concluded that the determination
of whether contracts are substantially different should be based on a qualitative evaluation of the existence
of certain key components in the replacement transaction.
A13.

In reference to the guidance in paragraph 11(a) of this SOP, AcSEC concluded that the

combination of mortality risk, morbidity risk, and the nature of the investment return rights and provisions in
a contract are the most significant factors in determining the inherent nature of the contract. However,
AcSEC concluded that all aspects of a contract should be reviewed when determining if the inherent nature
of the contract has changed. Significant changes in the balance of primary contract risks, such as mortality
or morbidity, as well as changes within kinds or degree of mortality or morbidity risks result in substantially
different contracts as they change the inherent nature of the original contract. An example of a change in
the degree of mortality risk would be an internal replacement of a variable annuity with an insignificant
death benefit to a variable annuity with a significant death benefit. Reunderwriting the entire contract may
be indicative of a change in inherent nature resulting from a change in the kind or degree of mortality or
morbidity risk. AcSEC also concluded that changes in the kind and character of the investment return
rights and provisions of the contract change the inherent nature of the contract because investment return
rights are a major component in the contractual relationship between the contract holder and the insurance
enterprise. AcSEC acknowledged that there is a significant difference between investment return rights and
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provisions and investment risk, and concluded that it is the nature of the contractual provisions relative to
the determination of investment return and not investment risk profile that determines the inherent nature of
a contract.
A14.

In reference to the guidance in paragraphs 11(b) and 14 of this SOP, AcSEC believes that the

requirement of an additional deposit, premium, or charge relating to the benefit provided under the replaced
contract, in excess of amounts contemplated in the replaced contract, indicates that the replacement
contract is not a continuation of the replaced contract due to the change of the underlying economics of the
replaced contract as a result of the internal replacement.
A15.

In reference to the guidance in paragraphs 11(c) and 15 of this SOP, AcSEC concluded that a net

decrease to the balance available to the contract holder would effectively be a surrender charge and,
therefore, be indicative of a change in the substance of the contract between the contract holder and the
insurance enterprise, rather than the continuation of the replaced contract.
A16.

In reference to the guidance in paragraphs 11(d) and 16 of this SOP, AcSEC also concluded that a

modification resulting in a change to the amortization method or revenue classification of the contract is
indicative of a substantive change in the contract because changes in amortization method or revenue
classification would indicate that the contracts should be accounted for under different accounting models.
Multiple accounting models exist to address the different kinds of products issued by insurance enterprises;
“insurance specific” accounting models are prescriptive, not elective; therefore, use of a different
accounting model implies a substantially different kind of contract. An analogy can be made to FASB
Statement No. 13, Accounting for Leases. Paragraph 9 of FASB Statement No. 13 requires a lease
agreement whose terms have been modified to be accounted for as a new agreement if the original
classification of the lease would have been different under the modification.
A17.

In reference to the guidance in paragraphs 11(e) and 17 of this SOP, AcSEC concluded that if

additional benefits, whether elected as a result of provisions of the original contract or provisions added
subsequently, do not become the primary benefits under the contract and the other conditions in paragraph
11 are satisfied, the internal replacement would be deemed not substantially different from the replaced
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contract. In evaluating contracts to determine the primary benefit, an insurance enterprise should consider
the expected present values of the different benefits provided under the contract and the relative
relationship of those benefits to each other. The primary benefit under the contract would be the most
significant benefit, but need not represent the majority of benefits.

Accounting for Internal Replacements That Are Substantially Different
A18.

Consistent with the analogy to guidance in EITF Issue No. 96-19 and the guidance in FASB

Statement No. 97 relative to the internal replacement of a traditional life insurance contract with a universal
life-type contract, AcSEC concluded that an internal replacement transaction that is determined to result in
a replacement contract that is substantially different from the original contract should be accounted for as
the extinguishment of the original contract and the issuance of a new contract. AcSEC concluded there was
no compelling reason to propose any modification to the accounting results that follow from the application
of current accounting guidance applicable to the termination of the original contract and the issuance of a
new contract.

Accounting for Internal Replacements That Are Not Substantially Different
A19.

Paragraph 15 of FASB Statement No. 97 requires that investment contracts issued by insurance

enterprises be accounted for in a manner consistent with interest-bearing instruments. EITF Issue No.
96-19 interpreted the guidance in FASB Statement No. 125, as amended by FASB Statement No. 140, to
conclude that certain debt exchanges do not contain substantive modifications to existing debt, resulting in
unamortized amounts related to the old debt and new fees exchanged between parties related to the
modified debt being amortized over the life of the modified debt. The EITF explicitly acknowledged that an
exchange or modification in terms that is not substantially different does not result in an extinguishment.

A20.

AcSEC concluded, based on the EITF Issue No. 96-19 model, that an internal replacement that is

determined to be not substantially different should be accounted for as a continuation of the original
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contract. As such, the unamortized deferred acquisition costs, deferred revenue liabilities, and deferred
sales inducement assets associated with the original contract should continue to be deferred.
A21.

FASB Statements No. 97; No. 120, Accounting and Reporting by Mutual Life Insurance Enterprises

and by Insurance Enterprises for Certain Long-Duration Participating Contracts; and No. 91, Accounting for
Nonrefundable Fees and Costs Associated with Originating or Acquiring Loans and Initial Direct Costs of
Leases, specify the treatment of revisions to estimated gross profits, estimated gross margins, and
estimated cash flows of contracts accounted for under these Statements. AcSEC concluded that it would
be appropriate to follow the existing accounting guidance that specifies the treatment of revisions to
estimated gross profits, estimated gross margins, and estimated cash flows. For contracts accounted for
under FASB Statement No. 60, Accounting and Reporting by Insurance Enterprises, the continuation of the
contract after an internal replacement transaction is not unlike a prospective adjustment of premiums on
indeterminate premium life insurance. Although not specifically addressed in existing accounting literature,
actuarial literature and practice have emerged to deal with that situation. Actuarial Standard of Practice No.
10, “Methods and Assumptions for Use in Life Insurance Company Financial Statements Prepared in
Accordance with GAAP,” addresses the accounting for indeterminate premium policies as follows:

Indeterminate Premium Policies. Provided the policy is not, in substance, a [universal life]type policy, [FASB Statement] No. 60 is applicable to indeterminate premium policies. The
premium flexibility associated with these policies may affect the application of [FASB
Statement] No. 60, such as the use of a smaller provision for the risk of adverse deviation.
The ability and willingness of the insurer to change premiums may be anticipated in
performing loss recognition. Assumptions may be “unlocked” at gross premium change
dates. If assumptions are adjusted, it should be done prospectively, without a change in the
liability as of the valuation date.

In such cases, DAC factors also are adjusted prospectively and there is no discontinuity in the balance of
unamortized deferred acquisition costs. Such a prospective revision in this and similar situations involving
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guaranteed renewable health insurance products, on which premiums may be adjusted prospectively, does
not violate the FASB Statement No. 60 “lock-in” concept.

A22.

AcSEC concluded that sales inducements offered in conjunction with an internal replacement that

is not substantially different and that otherwise meet the criteria of the proposed SOP Accounting and
Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate
Accounts should be deferred and amortized over the life of the contracts consistent with the existing longduration contract accounting model, because that would best reflect the economic substance of the internal
replacement transaction. One of the sales inducement criteria of the proposed SOP Accounting and
Reporting by Insurance Enterprise for Certain Nontraditional Long-Duration Contracts and for Separate
Accounts is that the sales inducement provision must be explicitly identified in the contract at contract
inception. In these situations, the sales inducement would be explicitly identified in the contract at the
inception of the replacement contract. AcSEC concluded that because for these transactions, the
replacement contract is accounted for as a continuation of the original contract, it would be appropriate to
account for the sales inducement as if it had been present in the original contract at the inception of the
contract. If surrender charges were assessed against the original contract in the internal replacement
transaction, it is appropriate to offset these surrender charges against immediate sales inducements on the
replacement contract to properly reflect the economics of the transaction and to determine the amount to
be accounted for as a deferred sales inducement asset on the replacement contract. Consistent with the
long-duration model and AcSEC’s conclusion that it would be appropriate to account for the sales
inducement as if it had been present since contract inception, deferred sales inducements are amortized
using methodologies and assumptions similar to those used for capitalized acquisition costs and based on
actual and estimated gross profits and margins that consider the entire life of the original and replacement
contracts. Any cumulative adjustment to the deferred sales inducement asset would be recorded in
earnings in the period in which the replacement transaction occurs.
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Costs Related to Internal Replacements
A23.

AcSEC concluded that an internal replacement that is not substantially different is, in substance, a

continuation of the original contract and therefore, any contract activity would be non-first-year activity and
should be accounted for accordingly. Costs related to an internal replacement that is not substantially
different should be evaluated for deferral under the provisions of FASB Statements No. 60 and No. 97
applicable for non-first-year, or renewal, acquisition costs. These renewal costs would be capitalized to the
extent that they meet the criteria for deferral as renewal acquisition costs under the provisions of FASB
Statements No. 60 and No. 97. AcSEC also concluded that it was unnecessary to provide guidance on the
amount of or kinds of costs that could be capitalized for internal replacements that are deemed to be not
substantially different, as such guidance already exists under the provisions of FASB Statements No. 60
and No. 97.

Recoverability
A24.

AcSEC concluded there was no reason to modify the existing guidance contained in FASB

Statement No. 60 as it relates to determining the recoverability of unamortized deferred acquisition costs
and present value of future profits.

Disclosures
A25.

AcSEC concluded that existing disclosure requirements relative to the financial statement balances

affected by internal replacements, such as deferred acquisition costs, unearned revenues, sales
inducements, benefit liabilities, and account balances, provide adequate disclosure of information that is
useful and informative to financial statement users. AcSEC considered various alternatives for disclosures
and did not identify any additional disclosure beyond accounting policies applicable to internal
replacements that would be useful. The notice to recipients accompanying this SOP seeks comments on
whether other disclosures would be beneficial to users of financial statements.
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Effective Date and Transition
A26.

This SOP is to be effective for internal replacements occurring in fiscal years beginning after

December 15, 2003. AcSEC believes this effective date will provide insurance enterprises sufficient time to
implement this SOP. AcSEC also concluded that it would also allow companies the alternative of early
adoption.
A27.

AcSEC considered requiring that the effect of adopting this SOP be reported as a cumulative

effect of a change in accounting principle (in accordance with the provisions of APB Opinion No. 20,
Accounting Changes). AcSEC rejected that alternative because the significant effort and cost likely to be
incurred to evaluate and produce the information that would be required to retroactively apply the new
guidance would exceed the benefits retroactive application might provide. AcSEC believes this treatment
is consistent with transition rules of other accounting guidance, such as AICPA SOP 98-1, Accounting for
the Costs of Computer Software Developed or Obtained for Internal Use, and the proposed SOP
Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts
and for Separate Accounts.

A28.

AcSEC concluded that the SOP should be applied prospectively for internal replacements occurring

after adoption because enterprises may not have accumulated the information at the level required by this
new guidance to enable the companies to identify deferred acquisition costs specific to prior internal
replacements.
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APPENDIX B
APPLICATION OF STATEMENT OF POSITION
PRODUCT AND PRODUCT FEATURE EXAMPLES

The following are examples of contract modifications that may or may not be considered internal
replacements and the application of the guidance in this SOP for evaluating whether the internal
replacements are substantially different from the replaced contracts.

Increasing Death Benefit Coverage on a Life Contract
B1.

There are several ways in which a contract holder can increase death benefit coverage on a

traditional life insurance contract.
Option to Purchase Additional Insurance Rider
B2.

An option to purchase additional insurance (OPA) rider gives the contract holder the right to

purchase additional insurance coverage. That is, the contract holder can increase policy face value of the
same type of insurance coverage and in the same form as that provided by the original contract. The
additional premium charged is not in excess of an amount that would be commensurate with the additional
insurance coverage obtained.
B3.

As the rider feature was included in the original contract and assuming the amount that could be

added is limited to an inflation adjustment it meets the criterion in paragraph 10(d) of this SOP and
therefore is not considered an internal replacement. If the OPA is not limited to an inflation adjustment, it
should be evaluated under the provisions of paragraph 11, and in this example the internal replacement is
determined to be not substantially different from the replaced contract. Even if this rider feature was added
to the contract subsequent to its issuance, the modification would satisfy the criteria of paragraph 11 of this
SOP and in this example the internal replacement would be deemed not substantially different from the
replaced contract, due to the following:
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a. The modification does not result in a change in the inherent nature of the contract because it is
the same type and form of coverage as the original contract.
b. The additional premium is not in excess of an amount commensurate with the additional
insurance coverage obtained and there are no changes in the charges related to the original
benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The modification does not result in a change to either the amortization method or revenue
classification of the contract.
e. The primary benefit of the contract has not changed.

Issuance of a Second Life Insurance Policy for an Incremental Face Amount
B4.

The contract holder obtains a second life insurance policy for an incremental face amount, with

underwriting required on the new policy only. The original contract remains in force without change.

B5.

This transaction does not fall within the definition of an internal replacement in paragraph 9 of this

SOP. The accounting for the original contract remains unchanged and the new contract is accounted for
independently of the original contract. Any deferrable acquisition costs associated with the new contract are
deferred and amortized according to the revenue/margin stream of the new contract.

Surrender of Original Contract and Issuance of a New Contract With an Increased Total Death
Benefit
B6.

The contract holder surrenders the original contract and obtains a new contract for the increased

total death benefit. In this example, the additional premium charged is not in excess of an amount that
would be commensurate with the additional insurance coverage obtained, no reunderwriting was required,
and there were no surrender fees or front-end fees associated with the internal replacement. This
exchange of a traditional life insurance contract for another traditional life insurance contract with increased
death benefit coverage results in an internal replacement that is deemed to be not substantially different
from the replaced contract, due to the following:
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a. The modification does not result in a change in the inherent nature of the contract and there is
no change in the kind and degree of mortality risk and no change in the nature of the
investment return rights and provisions (however, the implied crediting rate may have
changed).
b. The additional premium is not in excess of an amount commensurate with the additional
insurance coverage obtained and there are no changes in the charges related to the original
benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The modification does not result in a change to either the amortization method or revenue
classification of the contract.
e. The primary benefit of the contract has not changed.
The same conclusion would be reached if the internal replacement transaction involved the exchange of a
universal life contract for a new universal life contract or of a variable universal life contract for a new
variable universal life contract, with the fact pattern discussed above for an exchange of a traditional life
insurance contract. AcSEC acknowledges that the examples in paragraphs B4 and B6 of this SOP are
substantively the same, but will have slightly different accounting results due to the form of the transactions.
Administrative considerations and customer preferences generally would determine how the insurance
enterprise would structure the increased benefit.

If alternative structures result in significantly different

accounting results, the accounting should be determined based on the substance of the transaction.

Paid-Up Addition Rider (Life Contract)
B7.

A paid-up addition rider is an option under a participating life insurance policy by which the policy

owner can elect to have the dividends paid on the policy used to purchase single-premium paid-up
increments of permanent insurance.
B8.

Paragraph 10 of this SOP provides that paid-up additions to life insurance contracts are not

considered internal replacements.
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Single Premium Deferred Annuity to Market Value Adjusted Annuity
B9.

A single premium deferred annuity (SPDA) is a deferred general account annuity with a single

premium and guaranteed minimum crediting rate. The crediting rate on an SPDA may vary above the
minimum guaranteed rate at the discretion of the insurance enterprise. SPDAs typically are classified as
investment contracts under Financial Accounting Standards Board (FASB) Statement of Financial
Accounting Standards No. 97, Accounting and Reporting by Insurance Enterprises for Certain LongDuration Contracts and for Realized Gains and Losses from the Sale of investments.

B10.

A market value adjusted (MVA) annuity is a fixed deferred annuity that provides for return of

principal and guaranteed interest if held until a specified date or a calculated market adjusted value if
surrendered at an earlier date. MVA annuities typically are classified as FASB Statement No. 97 investment
contracts.
B11.

In this example, no additional deposit or premium is required and there are no surrender charges or

front-end fees associated with the internal replacement. The exchange of an SPDA contract for an MVA
contract results in contracts that are not substantially different due to the following:
a. The modification does not change the contractual rights and provisions for the determination of
the contract holder’s investment return. The difference between the SPDA and the MVA
annuity results from the manner in which the amount available to the contract holder is
determined in the event the contract is terminated prematurely, not the contractual rights and
provisions for the determination of the contract holder’s investment return in the absence of a
premature termination of the contract.
b. No additional deposit or premium is required and there are no changes in the charges related
to the original benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the original contract.
e. The primary benefit of the contract has not changed.
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Paragraph 18 of FASB Statement No. 97 has been generally interpreted as indicating that surrender
assessments are not anticipated in determining liability valuation. Therefore, AcSEC concluded it was
appropriate to not consider the difference in the surrender provisions of the SPDA and MVA annuities in
evaluating the inherent natures of these types of contracts.
Single Premium Deferred Annuity to Equity-Indexed Annuity
B12.

An SPDA has a crediting rate that is set at the discretion of the insurance enterprise. An equity-

indexed annuity is a deferred fixed annuity contract with a guaranteed minimum crediting rate plus a
contingent return based on a contractually specified internal or external equity index. Equity-indexed
annuities typically are classified as FASB Statement No. 97 investment contracts with FASB Statement No.
133 embedded derivatives that are required to be bifurcated from the contract and accounted for
separately.

B13.

The exchange of an SPDA contract for an equity-indexed annuity results in an internal replacement

that is deemed to be substantially different because the nature of the contract holder’s investment return
rights and provisions differs significantly between the two contracts. The crediting rate of the SPDA contract
is declared at the discretion of the insurance enterprise, and the equity-indexed annuity is contractually
determined by reference to a pool of assets, an index, or other specified formula.

Single Premium Deferred Annuity to Multi-Bucket Annuity
B14.

An SPDA has a crediting rate that is set at the discretion of the insurance enterprise. A multi-

bucket annuity is a general account deferred annuity in which, subject to a contractually specified minimum
crediting rate, the interest rate to be credited on the contract holder’s account balance is determined based
on the returns achieved on a specified category of investments or investment strategy selected by the
contract holder. The contract specifies the rights and provisions for the determination of investment return
to the contract holder.

B15.

The exchange of an SPDA contract for a multi-bucket annuity results in an internal replacement

that is deemed to be substantially different, because the contractual rights and provisions for the
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determination of the contract holder’s investment return are different between the two contracts. In the case
of the typical SPDA, the interest rate is declared at the discretion of the insurance enterprise, whereas in
the case of the multi-bucket annuity, the determination of the interest rate is specified by the contract.

Fixed Interest Rate Guaranteed Investment Contract to a Variable Interest Rate Guaranteed
Investment Contract
B16.

A fixed interest rate guaranteed investment contract (GIC) has a stated fixed crediting rate

guaranteed for a specified period. An example of a variable interest rate GIC is a contract with a credited
interest rate defined as London Inter Bank Offer Rate (LIBOR) plus a specified spread. Both kinds of GIC
contracts are classified as FASB Statement No. 97 investment contracts.

B17.

The exchange of a fixed rate GIC for a variable rate GIC results in an internal replacement that is

deemed to be substantially different because the contractual rights and provisions for the determination of
the contract holder’s investment return are different between the two contracts. In the case of the fixed rate
GIC, the interest rate is fixed and guaranteed, whereas in the case of the variable interest rate GIC, the
investment return to the contract holder is contractually specified to be determined based on the returns
achieved on a specified category of investments or tied to a specific index.

Variable Annuity With Insignificant Death Benefit Guarantee to Variable Annuity With Significant
Death Benefit Guarantee
B18.

A variable annuity is a product offered by an insurance enterprise in which the contract holder’s

payments are used to purchase units of a separate account. The contract holder directs the allocation of
the account value among various investment allocation alternatives and bears the investment risk. The
units may be surrendered for their current value in cash (often less a surrender change) or applied to
purchase annuity income contracts. The insurance enterprise periodically deducts mortality and expense
charges from the account. Variable annuities are typically classified as FASB Statement No. 97 investment
contracts.
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B19.

A common feature in variable annuities is a minimum guaranteed death benefit (MGDB), with some

MGDB designs providing more extensive benefits than others. An exchange of a variable annuity contract
that contains an MGDB that is determined to be not significant with a variable annuity contract that contains
an MGDB that is determined to be significant, results in a replacement contract that is deemed to be
substantially different from the replaced contract as the inherent nature of the contract has changed
because the replacement contract contains significant mortality risk.
Variable Annuity With No Death Benefit Guarantee to Variable Annuity With Insignificant Death
Benefit Guarantee
B20.

The exchange of a variable annuity with no death benefit guarantee for a variable annuity that

contains an MGDB that is determined to be not significant, results in an internal replacement that is
deemed to be not substantially different from the replaced contract due to the following:
a. The addition of an MGDB with nominal mortality risk results in a minor change in the degree of
mortality risk and therefore does not change the inherent nature of the contract.
b. No additional deposit or premium is required, and there are no changes in the charges related
to the original benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the original contract.
e. The primary benefit of the contract has not changed.
Variable Annuity With One Kind of Significant Death Benefit Guarantee to Variable Annuity With
Another Kind of Significant Death Benefit Guarantee
B21.

In this example, it is assumed that both the variable annuity with the roll up MGDB and the variable

annuity with the ratchet MGDB offered as an internal replacement are determined to have significant
mortality risk. It is also assumed that there is no reunderwriting required for the transaction, no additional
deposit required to effect the transaction, and no net decrease in the balance available to the contract
holder prior to surrender charges. In this example, the replacement results in additional mortality and
expense charges due to the enhanced benefit not in excess of an amount commensurate with the added
benefit. An exchange of a variable annuity contract that contains an MGDB that is determined to be
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significant with a variable annuity contract that contains another kind of MGDB that is also determined to be
significant, results in an internal replacement that is deemed to be not substantially different from the
replaced contract due to the following:
a. The modification does not result in a change in the inherent nature of the contract because it
results in a minor change in the kind and degree of mortality risk.
b. No additional deposit or premium is required and the additional charges are not in excess of an
amount commensurate with the benefit.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the original contract.
e. The primary benefit of the contract has not changed.
Variable Annuity With New Investment Alternatives Added
B22.

Variable annuities generally have a number of investment allocation alternatives from which the

contract holder may select. In the normal course of business, companies modify these elections for a
number of reasons, including competition and changes in investment management and distribution
relationships. Throughout the life of the contract, the contract holder has the option to select new
allocations for the investment of his or her annuity account balance. Paragraph 12 of this SOP provides that
the addition of new investment allocation alternatives to variable life insurance and annuity contracts does
not change the inherent nature of the original contract because the contractual rights and provisions for the
determination of the contract holder’s investment return have not changed.

B23.

It is possible that one of the investment allocation alternatives added could be a fixed return option.

As long as the base contract remained a variable annuity contract, the modified contract would continue to
be considered a not substantially different contract. If, however, the contract holder’s election of the fixed
allocation alternative resulted in a conversion or partial conversion to a fixed annuity contract, the internal
replacement would be considered to result in a substantially different contract to the extent of the
conversion.
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Variable Annuity to Variable Annuity With Guaranteed Minimum Accumulation Benefit
B24.

A variable annuity contract is replaced with a variable annuity contract that also provides a

guaranteed minimum accumulation benefit (GMAB), in this example, a 5 percent annual rollup of contract
value in 10 years. Assuming there is no retroactive charge for this benefit, this results in an internal
replacement that is deemed to be not substantially different from the replaced contract, due to the following:
a. This modification does not change the fundamental nature of the investment return right, which
remains the pass through of actual investment performance resulting from the investment
alternatives selected by the contract holder. The GMAB is an additional feature that does not
negate the nature of the original investment return provisions; it is the purchase of an additional
benefit.
b. No additional deposit or premium is required, and there are no changes in the charges related
to the original benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the contract.
e. The primary benefit of the contract has not changed.
The GMAB would, however, be classified and accounted for as a derivative under FASB Statement No.
133, Accounting for Derivative Instruments and Hedging Activities, as amended.

Variable Annuity to Variable Annuity With Guaranteed Minimum Income Benefit
B25.

A variable annuity contract is replaced with a variable annuity contract that also provides a

guaranteed minimum income benefit (GMIB), in this example, a 5 percent annual rollup of contract value. A
GMIB specifies a manner in which an annuitization benefit is determined if the contract holder elects to
annuitize. The GMIB benefit cannot be withdrawn or net settled. Assuming there is no retroactive charge for
this benefit, this results in an internal replacement that is deemed to be not substantially different from the
replaced contract due to the following:
a. This modification does not change the fundamental nature of the investment return right during
the accumulation phase of the contract, which remains the pass through of actual investment
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performance resulting from the investment alternatives selected by the contract holder. The
GMIB is an additional feature that does not negate the nature of the original investment return
provisions; it is the purchase of an additional benefit.
b. No additional deposit or premium is required, and there are no changes in the charges related
to the original benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the contract.
e. The primary benefit of the contract has not changed.
In accordance with the guidance in FASB Statement No. 97, if the contract holder elects to annuitize, the
annuity would be accounted for as a new contract at the time of annuitization. In circumstances other than
this example, the GMIB could be classified and accounted for as a derivative under FASB Statement No.
133, as amended, if the embedded derivative can be net settled.
Variable Annuity to Variable Annuity With Guaranteed Minimum Withdrawal Benefit
B26.

A guaranteed minimum withdrawal benefit (GMWB) provides a contract holder a guarantee that a

minimum amount (usually stated as a percentage of premiums) will be available for withdrawal over a
specific period. Regardless of the contract value, the contract holder is guaranteed the right to periodic
withdrawals from the contract until the amount of premiums deposited into the contract is withdrawn. The
insurance enterprise either offers to "replace" deferred annuity contracts with annuity contracts that contain
the GMWB feature or the insurance enterprise adds a GMWB rider to existing inforce business (that is,
deferred annuity contracts). There is a fee charged for the GMWB feature that is not in excess of an
amount that would be commensurate with the benefit obtained.

B27.

A variable annuity with a GMWB is classified as an FASB Statement No. 97 investment contract

with an embedded derivative. Assuming there is no retroactive charge for this benefit, the exchange of a
variable annuity with no GMWB for a variable annuity with a GMWB results in an internal replacement that
is deemed to be not substantially different from the replaced contract due to the following:

49

a. This modification does not change the fundamental nature of the investment return right, which
remains the pass through of actual investment performance resulting from the investment
alternatives selected by the contract holder. The GMWB is an additional feature that does not
negate the nature of the original investment return provisions; it is the purchase of an additional
benefit.
b. No additional deposit or premium is required and the fee charged is not in excess of an amount
that was commensurate with the benefit obtained.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the contract.
e. The primary benefit of the contract has not changed.
The GMWB would, however, be classified and accounted for as a derivative under FASB Statement No.
133, as amended.
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APPENDIX C
ILLUSTRATION OF DEFERRED ACQUISITION COSTS AND UNEARNED REVENUE
LIABILITY AMORTIZATION FOR A FASB STATEMENT NO. 97 INTERNAL REPLACEMENT
THAT IS DETERMINED TO BE NOT SUBSTANTIALLY DIFFERENT

C1.

In the illustrative example, an insurance enterprise is offering to replace its general account single

premium deferred annuity (SPDA) contracts with newer general account SPDA contracts. No surrender
charges from the original contract will be imposed on contract holders who elect to have their contracts
replaced. A modest commission will be paid to agents at the time of replacement. The contract holder who
elects the new policy will receive a higher interest crediting rate than under the older contract but must
accept a new surrender charge period in exchange. The insurance enterprise expects that persistency
rates will improve under the replacement contracts both from the new surrender charge period and the
higher credited interest.
C2.

The exchange of an SPDA contract for a newer SPDA contract in this example results in an internal

replacement that is deemed not substantially different, due to the following:
a. The modification does not result in a change in the inherent nature of the contract.
b. An additional deposit or premium is not required, and there are no changes in the charges
related to the original benefits.
c.

There is no net decrease in the balance available to the contract holder.

d. The replacement does not result in a change to the amortization method or revenue
classification of the contract.
e. The primary benefit of the contract has not changed.

C3.

As a result of the replacement, the present value of future estimated gross profits (EGPs) is

expected to increase due to the improved persistency. This will result in an increase in unamortized
deferred acquisition costs and an increase in unearned revenue liability at the time of the replacement.
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C4.

In the illustration, the insurance enterprise has chosen to let the discount rate fluctuate with

changes in interest crediting rates.1
C5.

The following schedules are included in the illustrated example:
Schedule 1 – Original deferred acquisition costs (DAC) and unearned revenue liability (URL)
amortization before replacement
Schedule 2 – Replacement contract estimated gross profits (EGPs), DAC, and front-end fees
Schedule 3 – Account value and interest crediting rates from original and replacement policies
Schedule 4 – Combined EGPs, acquisition costs, and front-end fees
Schedule 5 – Revised amortization of DAC and URL after replacement, given revised
estimated gross profits
Schedule 6 – Summary of DAC and URL as a result of internal replacement that is not
substantially different

1

In accordance with the guidance in paragraph 25 of Financial Accounting Standards Board Statement of Financial Accounting No.
97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and Losses
from the Sale of Investments.
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Schedule 1 - Original Contracts Deferred Acquisition Costs and
Unearned Revenue Liability Amortization Before Replacement
Policy

Discount

Account
Value

Year

Rate
(a)
6.00%

End of Year
(b)
$30,694,950

1 (Act.)
2 (Act.)
3 (Act.)
4 (Act.)
5 (Act.)
6 (Proj.)
7 (Proj.)
8 (Proj.)
9 (Proj.)
10 (Proj.)
11 (Proj.)
12 (Proj.)
13 (Proj.)
14 (Proj.)
15 (Proj.)
16 (Proj.)
17 (Proj.)
18 (Proj.)
19 (Proj.)
20 (Proj.)

Acquisition

Estimated
Gross

DAC
Balance

Frontend
Deposits
Costs
Fees
Profits
End of Year
(c)
(d)
(e)
(f)
(g)
$30,000,00 $1,925,000 $300,000 $305,094 $1,772,965
0
–
–
–
356,730 1,584,257
–
–
–
517,263 1,249,490
–
–
–
549,372
848,964
–
–
–
414,428
532,247
–
–
–
253,964
338,821
–
–
–
149,039
226,764
–
–
–
81,593
167,687
–
–
–
60,646
123,729
–
–
–
45,060
91,021
–
–
–
33,468
66,679
–
–
–
24,850
48,556
–
–
–
18,445
35,052
–
–
–
13,687
24,977
–
–
–
10,154
17,447
–
–
–
7,531
11,803
–
–
–
5,584
7,556
–
–
–
4,140
4,341
–
–
–
3,068
1,890
–
–
–
2,273
–
$1,925,000 $300,000 $2,195,242
0.87690 0.13666

Unearned
Revenue
Balance
End of Year
(h)
$276,306

7.00
31,201,417
246,897
7.50
28,510,294
194,726
6.50
22,772,598
132,306
5.50
16,817,563
82,948
5.50
12,419,771
52,803
5.50
9,172,001
35,340
5.50
6,773,522
26,133
5.50
5,002,246
19,283
5.50
3,694,159
14,185
5.50
2,728,136
10,392
5.50
2,014,729
7,567
5.50
1,487,877
5,463
5.50
1,098,797
3,893
5.50
811,462
2,719
5.50
599,265
1,839
5.50
442,557
1,177
5.50
326,828
677
5.50
241,363
294
5.50
–
–
Present values
k factor
Explanation of columns:
(a) Discount rate for FASB Statement No. 97 product, which is rate that accrues to policyholder balances
(b) Prior year-end account value plus premiums plus interest credited less fees less withdrawals
(c) Premium deposits at beginning of policy year
(d) Deferred acquisition costs at beginning of year as defined in FASB Statement No. 97
(e) Front-end fees charged to policyholders at beginning of year for services to be provided over life of contract
(f) Estimated gross profits as defined in FASB Statement No. 97
(g) Ending DAC balance as defined in FASB Statement No. 97 using EGPs as basis for amortization
(h) Ending URL balance as defined in FASB Statement No. 97 using EGPs as basis for amortization

03/05/03
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Schedule 2 – Replacement Contract Estimated Gross Profits, Deferred Acquisition Costs and
Front-end Fees
Per $100,000 of Account Value at End of 5th year
Account
Estimated
Policy
Value
Acquisition Front-end
Gross
Discount
Year
End of Year
Costs
Fees
Profits
Rate
0.005946165
(a)
(b)
(c)
(d)
(e)
At
Replacement
$100,000
6 (Proj.)
103,106
$1,250
–
$812.17
5.75%
7 (Proj.)
103,583
–
–
980.58
5.75
8 (Proj.)
101,324
–
– 1,073.82
5.75
9 (Proj.)
96,435
–
– 1,083.24
5.75
10 (Proj.)
89,232
–
– 1,010.93
5.75
11 (Proj.)
80,209
–
–
869.42
5.75
12 (Proj.)
69,977
–
–
679.52
5.75
13 (Proj.)
59,201
–
–
466.68
5.75
14 (Proj.)
50,084
–
–
397.49
5.75
15 (Proj.)
42,371
–
–
338.42
5.75
16 (Proj.)
35,846
–
–
288.01
5.75
17 (Proj.)
30,325
–
–
245.03
5.75
18 (Proj.)
25,655
–
–
208.39
5.75
19 (Proj.)
21,704
–
–
177.17
5.75
20 (Proj.)
–
–
–
150.59
5.75
Explanation of columns:
(a)
Prior account value plus premiums plus interest credited less fees less withdrawals
(b)
Deferred acquisition costs at beginning of year as defined in FASB Statement No. 97
(c)
Front-end fees charged to policyholders at beginning of year for services to be provided over
life of contract
(d)
Estimated gross profits as defined in FASB Statement No. 97
(e)
Discount rate for FASB Statement No. 97 product, which is rate at which policyholder's funds
accumulate
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Schedule 3 - Account Value and Crediting Rates of Original and Replacement Contracts
50% of Original Contracts' Account Value Replaced with New Policies

Policy
Year
At Issue
1
2
3
4
5
At
Replacement
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Interest
Interest
Interest
Acct. Value Acct. Value Crediting
Crediting
Crediting
End of Year End of Year
Rate
Rate
Rate
Original Replacement Original Replacement Weighted
Policies
Policies
Policies
Policies
Average
(a)
(b)
(c)
(d)
(e)
$29,700,00
–
6.00%
–
6.00%
0
30,694,950
–
7.00
–
7.00
31,201,417
–
7.50
–
7.50
28,510,294
–
6.50
–
6.50
22,772,598
–
5.50
–
5.50
16,817,563
8,408,782 $8,408,782
5.50
5.75%
5.63
6,209,885
4,586,000
3,386,761
2,501,123
1,847,079
1,364,068
1,007,364
743,939
549,399
405,731
299,632
221,278
163,414
120,681
–

8,669,979
8,710,078
8,520,090
8,108,995
7,503,355
6,744,578
5,884,223
4,978,052
4,211,432
3,562,872
3,014,190
2,550,004
2,157,304
1,825,079
–

5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
5.50
–

5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
–

5.65
5.66
5.68
5.69
5.70
5.71
5.71
5.72
5.72
5.72
5.73
5.73
5.73
5.73
–

Explanation of columns:
(a)
Account value at the end of the policy year for original contract
(b)
Account value at the end of the policy year for replacement contract
(Example assumes original contracts' surrender charges were waived for
replacements.)
(c)
Interest crediting rate on original contract
(d)
Interest crediting rate on replacement contract
(e)
Interested crediting rate weighted by account value

03/05/03

55

Schedule 4 - Combined Estimated Gross Profits, Deferred Acquisition Costs, and Unearned
Revenue Liability
50% of Original Contracts' Account Value Replaced With New
Estimated
Estimated
Deferred
Deferred
Gross
Gross
Acquisition Acquisition
Profits
Profits
Estimated
Costs
Costs
Deferred
Policy
Original
Replacement
Gross
Original
Replacement Acquisition
Year
Policies
Policies
Profits
Policies
Policies
Costs
(a)
(b)
(c)
(d)
(e)
(f)
1 (Act.)
$305,094
– $305,094 $1,925,000
– $1,925,000
2 (Act.)
356,730
–
356,730
–
–
–
3 (Act.)
517,263
–
517,263
–
–
–
4 (Act.)
549,372
–
549,372
–
–
–
5 (Act.)
414,428
–
414,428
–
–
–
6 (Proj.)
126,982
$68,294
195,276
–
$105,110
105,110
7 (Proj.)
74,520
82,455
156,975
–
–
–
8 (Proj.)
40,797
90,295
131,092
–
–
–
9 (Proj.)
30,323
91,087
121,410
–
–
–
10 (Proj.)
22,530
85,007
107,537
–
–
–
11 (Proj.)
16,734
73,107
89,841
–
–
–
12 (Proj.)
12,425
57,140
69,565
–
–
–
13 (Proj.)
9,223
39,242
48,465
–
–
–
14 (Proj.)
6,844
33,424
40,268
–
–
–
15 (Proj.)
5,077
28,457
33,534
–
–
–
16 (Proj.)
3,765
24,218
27,984
–
–
–
17 (Proj.)
2,792
20,604
23,396
–
–
–
18 (Proj.)
2,070
17,523
19,593
–
–
–
19 (Proj.)
1,534
14,898
16,432
–
–
–
20 (Proj.)
1,137
12,663
13,799
–
–
–
2,374,791
$2,001,726
Present values
0.8429
k factor
Explanation of columns:
(a)
Estimated gross profits (EGPs) from original policies
(b)
EGPs from replacement policies
(c)
Total EGPs
(d)
Deferred acquisition costs from original policies
(e)
Deferred acquisition costs from replacement policies
(f)
Total deferred acquisition costs
(g)
Front-end fees from original policies
(h)
Front-end fees from replacement policies
(i)
Total front-end fees
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Policies
FrontFrontEnd
End
Fees
Fees
Original Replacement
Policies
Policies
(g)
(h)
$300,000
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

FrontEnd
Fees
(i)
$300,000
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
$300,000
0.1263

Schedule 5 – Revised DAC and Unearned Revenue Liability Amortization After Replacement, Given
Revised Estimated Gross Profits
Policy
Year
1 (Act.)

<---------------------- DAC Amortization --------------------->
Acquisition
Interest
DAC
Costs
Added
Amortization
(EOY)
(a)
(b)
(c)
(d)
$1,925,000

2 (Act.)
3 (Act.)
4 (Act.)
5 (Act.)
6 (Proj.)
7 (Proj.)
8 (Proj.)
9 (Proj.)
10 (Proj.)
11 (Proj.)
12 (Proj.)
13 (Proj.)
14 (Proj.)
15 (Proj.)
16 (Proj.)
17 (Proj.)
18 (Proj.)
19 (Proj.)
20 (Proj.)

–
–
–
–
105,110
–
–
–
–
–
–
–
–
–
–
–
–
–
–

Explanation of columns:
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)

$115,500
124,833
120,561
83,982
50,212
40,441
33,580
28,095
23,491
19,054
15,005
11,558
8,879
7,058
5,524
4,225
3,119
2,169
1,347
631

<----- Unearned Revenue Amortization ----->
Front-end
Interest
URL
Fees
Added
Amortization
(EOY)
(e)
(f)
(g)
(h)

$(257,165)

$1,783,335

$300,000

$18,000

$(38,542)

$279,458

(300,690)
(436,004)
(463,069)
(349,324)
(164,599)
(132,315)
(110,498)
(102,338)
(90,643)
(75,728)
(58,636)
(40,852)
(33,942)
(28,266)
(23,588)
(19,720)
(16,515)
(13,851)
(11,632)

1,607,478
1,292,035
912,948
613,837
594,788
496,053
413,650
334,803
263,214
202,490
155,412
123,440
96,556
73,814
54,452
37,850
23,504
11,001
–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

19,562
19,047
13,498
8,347
6,061
5,033
4,211
3,521
2,856
2,249
1,732
1,331
1,058
828
633
467
325
202
95

(45,065)
(65,344)
(69,400)
(52,353)
(24,669)
(19,830)
(16,560)
(15,337)
(13,585)
(11,349)
(8,788)
(6,122)
(5,087)
(4,236)
(3,535)
(2,956)
(2,475)
(2,076)
(1,743)

253,956
207,658
151,756
107,749
89,141
74,344
61,994
50,177
39,448
30,347
23,292
18,500
14,471
11,063
8,161
5,673
3,523
1,649
–

Total acquisition costs from original and replacement policies
Interest on deferred
acquisition costs
(DAC)
DAC amortization (k-factor x EGP)
Ending DAC (a)+(b)+(c)
Total front-end fees from original and replacement policies
Interest on URL
URL amortization (k-factor x EGP)
Ending URL
(e)+(f)+(g)
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Schedule 6 - Summary of DAC and URL as a Result of Internal Replacement That Is Not
Substantially Different

Original (year 5 balances)
After replacement (year 5 balances)

Unearned
Revenue
DAC
Liability
$532,247 $ 82,948
613,837
107,749
(81,589) (24,801)

Summary of Accounting Entries
DAC

$81,589
DAC Amortization
$81,589

Change in Unearned Revenue
Unearned Revenue Liability

$24,801
$24,801
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GLOSSARY

existing contract. The contract that currently is held by the contract holder, which may have
been modified from its original form.
general account. All operations of an insurance enterprise that are not reported in a separate
account.
original contract. The initial contract that originated the relationship of the contract holder and
the insurance enterprise for the benefit specified.
primary benefit. The primary benefit under the contract would be the most significant benefit but
need not represent the majority of benefits.
ratchet death benefit. A death benefit equal to the highest account balance among prior
specified anniversary dates adjusted for deposits less partial withdrawals since the specified
anniversary date.
replaced contract.
transaction.

The contract that is exchanged or modified in an internal replacement

replacement contract. The new or modified contract in an internal replacement transaction.
return of premium death benefit. A death benefit equal to the total deposits made by the
contract holder less any withdrawals.
reunderwriting. The reexamination of the insurance risk of the entire contract for purposes of
acceptance or rejection or for rating the risk for pricing purposes.
roll up death benefit. A death benefit equal to the total of deposits made to the contract less an
adjustment for partial withdrawals, accumulated at a specified interest rate.
sales inducement. A product feature that enhances the investment yield to the contract holder.
The three main types of sales inducements are (1) day one bonus, which increases the account
value at inception, also called immediate bonus; (2) persistency bonus, which increases the
account value at the end of a specified period; and (3) enhanced yield, which credits interest for a
specified period in excess of rates currently being offered for other similar contracts. Bonuses
can be defined as contractually obligated inducements that are explicitly identified in the contract
and are in excess of current market conditions.
separate account. A separate investment account established and maintained by an insurance
enterprise under relevant state insurance law to which funds have been allocated for certain
contracts of the insurance enterprise or similar accounts used for foreign originated products.
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